Name: PHENOMEX INC (CELL) Stock
Brand: PHENOMEX INC
Rating: 5 (3 reviews)

CELL Latest News, Press Relases and Analysis

All

Press Releases

2 years ago - By: PhenomeX

PhenomeX Announces Opto® Memory B Discovery Human Workflow on the Beacon® Optofluidic Platform

2 years ago - By: PhenomeX

PhenomeX Announces the Release of SpotLight™ Human Lambda Reagent for the Beacon® Platform to Accelerate Cell Line Development Workflows

2 years ago - By: PhenomeX

PhenomeX to Participate in Upcoming Cell Biology Conferences

2 years ago - By: PhenomeX

PhenomeX Unveils Meteor™ Chips For Quantitative Bulk Analysis On The IsoSpark™ Platform To Revolutionize High Throughput Multiplexed Hands-Free Proteomics

2 years ago - By: Kahn Swick & Foti, LLC

PHENOMEX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of PhenomeX Inc. - CELL

2 years ago - By: Benzinga - Mentions: BRKR

Health Care Company Bruker Announces Acquisition of PhenomeX

2 years ago - By: PhenomeX - Mentions: BRKR

PhenomeX Inc. Announces Commencement of Cash Tender Offer by Bruker

2 years ago - By: Benzinga - Mentions: EXAS BA CAT UAL ...

Cathie Wood's Bullish Stance on Flying Cars: Ark Buys $3.9M Worth of Archer Aviation Shares

2 years ago - By: Kahn Swick & Foti, LLC

PHENOMEX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of PhenomeX Inc. - CELL

2 years ago - By: PhenomeX

PhenomeX neemt deel aan Antibody Engineering & Therapeutics Europe 2023

2 years ago - By: PhenomeX

PhenomeX nimmt an der Antibody Engineering & Therapeutics Europe 2023 teil

2 years ago - By: PhenomeX

PhenomeX to Participate in Antibody Engineering & Therapeutics Europe 2023

2 years ago - By: BusinessInsider - Mentions: MS DCBO AMWD SWK ...

Benzinga's Top Ratings Upgrades, Downgrades For August 18, 2023

2 years ago - By: Halper Sadeh LLC

CELL Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of PhenomeX Inc. Is Fair to Shareholders

2 years ago - By: Ademi LLP

Shareholder Alert: Ademi LLP investigates whether PhenomeX Inc. has obtained a Fair Price in its transaction with Bruker Corporation

2 years ago - By: Seeking Alpha - Mentions: BRKR

Bruker buys PhenomeX for $108M cash (NASDAQ:BRKR)

2 years ago - By: Bruker Corporation - Mentions: BRKR

Bruker Corporation and PhenomeX Inc. Announce Definitive Agreement for Bruker to Acquire PhenomeX in All-Cash Transaction

2 years ago - By: PhenomeX

PhenomeX Reports Second Quarter 2023 Financial Results and Provides Business Update

2 years ago - By: PhenomeX

PhenomeX to Report Second Quarter 2023 Financial Results on August 14, 2023

2 years ago - By: PhenomeX

PhenomeX Announces Lifting of the Stay in AbCellera Patent Infringement Case

2 years ago - By: PhenomeX

PhenomeX's Beacon® Technology Enables Early Identification of Potent Omicron-Neutralizing Antibodies

2 years ago - By: PhenomeX

PHENOMEX INC (CELL) Stock News

CELL Latest News, Press Relases and Analysis

PhenomeX Announces Opto® Memory B Discovery Human Workflow on the Beacon® Optofluidic Platform

PhenomeX Announces the Release of SpotLight™ Human Lambda Reagent for the Beacon® Platform to Accelerate Cell Line Development Workflows

PhenomeX to Participate in Upcoming Cell Biology Conferences

PhenomeX Unveils Meteor™ Chips For Quantitative Bulk Analysis On The IsoSpark™ Platform To Revolutionize High Throughput Multiplexed Hands-Free Proteomics

PHENOMEX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of PhenomeX Inc. - CELL

Health Care Company Bruker Announces Acquisition of PhenomeX

PhenomeX Inc. Announces Commencement of Cash Tender Offer by Bruker

Cathie Wood's Bullish Stance on Flying Cars: Ark Buys $3.9M Worth of Archer Aviation Shares

PHENOMEX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of PhenomeX Inc. - CELL

PhenomeX neemt deel aan Antibody Engineering & Therapeutics Europe 2023

PhenomeX nimmt an der Antibody Engineering & Therapeutics Europe 2023 teil

PhenomeX to Participate in Antibody Engineering & Therapeutics Europe 2023

Benzinga's Top Ratings Upgrades, Downgrades For August 18, 2023

CELL Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of PhenomeX Inc. Is Fair to Shareholders

Shareholder Alert: Ademi LLP investigates whether PhenomeX Inc. has obtained a Fair Price in its transaction with Bruker Corporation

Bruker buys PhenomeX for $108M cash (NASDAQ:BRKR)

Bruker Corporation and PhenomeX Inc. Announce Definitive Agreement for Bruker to Acquire PhenomeX in All-Cash Transaction

PhenomeX Reports Second Quarter 2023 Financial Results and Provides Business Update

PhenomeX to Report Second Quarter 2023 Financial Results on August 14, 2023

PhenomeX Announces Lifting of the Stay in AbCellera Patent Infringement Case

PhenomeX's Beacon® Technology Enables Early Identification of Potent Omicron-Neutralizing Antibodies

PhenomeX Launches Beacon Quest™ Optofluidic System with Opto® T Cell Profiling Workflows